NJ

Noel Jee

Partner at Novo Holdings

San Francisco, California

Overview 

Noel Jee is a Life Science Investor based in San Francisco, California, with a background in venture capital and management consulting. Currently a Partner at Novo Holdings, Jee has excelled in strategic consulting and due diligence within the life sciences sector, holding key roles at prominent firms like Sofinnova Investments and Illumina Ventures. Jee's career highlights include serving as a Principal at Sofinnova Investments and Illumina Ventures, where he demonstrated expertise in financial modeling, data analysis, and strategic consulting within the biotechnology and healthcare industries.

Work Experience 

  • Partner

    2023 - Current

  • Board Observer

    2022 - 2023

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

Raised $140,699,993.00 from Longitude Capital, WS Investment Company, Avidity Partners, GC&H Investments, Sofinnova Investments, Biotechnology Value Fund, Vida Ventures, AbbVie and Surveyor Capital.

  • Principal

    2021 - 2023

Sofinnova Investments specializes in seed, startup, mid, early stage, series A, first venture round, and corporate spinouts.

  • Board Observer

    2020 - 2021

Pattern Bioscience is a biotech diagnostics company that helps to combat the problem of antibiotic resistance.

Raised $54,650,000.00 from Antimicrobial resistance, Omnimed Capital, Daleshaw and Illumina Ventures.

  • Board Observer

    2020 - 2021

  • Board Observer

    2020 - 2021

  • Chief Operating Officer

    2019 - 2020

Rebus Biosystems is a life science technology company creating revolutionary tools to enable spatial omics research without compromise.

Raised $37,761,424.00 from Illumina Ventures, LabGenomics, Timepolio Asset Management, Lifecore Partners, CTK Investments, NCore Ventures and Xoloninvest.

  • Board Observer

    2017 - 2021

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

Raised $47,000,000.00 from FusionX Ventures, Vertical Venture Partners, Illumina Ventures, Warburg Pincus, Casdin Capital, Sagian Equity and Anzu Partners.

  • Principal

    2017 - 2021

    Source, diligence, and invest in disruptive early-stage life science startups. Provide operational support to portfolio companies.

Illumina Ventures visions is to improve human health by unlocking the power of the genome.

  • Senior Life Science Specialist

    2015 - 2017

    Strategy consulting for large / small-cap biopharma companies and diagnostics companies. Therapeutic areas included oncology, GI, metabolic, cardiovascular, and autoimmune diseases.

  • Graduate Student

    2009 - 2015

    Chemistry, cell biology, and bioengineering - with a cancer-focused wrapper.

  • Catalyst Student Intern: Digital Health Track

    2014 - 2014

Articles About Noel

Relevant Websites